Skip to main content
Erschienen in: Current Nutrition Reports 1/2016

01.03.2016 | Cancer (MF Leitzmann, Section Editor)

Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

verfasst von: Mandi M. Hopkins, Kathryn E. Meier

Erschienen in: Current Nutrition Reports | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Omega-3 fatty acids (n-3 FAs) are thought to have many health benefits, among them are prevention of heart disease, depression, and various types of cancer, including prostate cancer. Basic and animal research studies have established that treatment with, or diets high in, n-3 FAs inhibit the progression of prostate cancer. Although several human epidemiological studies have come to the same conclusion, the results between epidemiological studies are not consistent. Some epidemiological studies have even found a positive correlation between prostate cancer and n-3 FAs, although the majority of epidemiological studies and meta-analyses have found no correlation. This discrepancy has a number of potential causes, the foremost being that human studies have considerably more variables to contend with than studies involving cell cultures or animals. The variations between epidemiological studies point to the need for better controlled, larger-scale, epidemiological studies, and more preclinical studies to elucidate the mechanism of action of n-3 FAs.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr Suppl. 2012;2:S228–239.CrossRef Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr Suppl. 2012;2:S228–239.CrossRef
3.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed
4.
Zurück zum Zitat Nithipatikom K, Campbell WB. Roles of eicosanoids in prostate cancer. Futur Lipidol. 2008;3(4):453–67.CrossRef Nithipatikom K, Campbell WB. Roles of eicosanoids in prostate cancer. Futur Lipidol. 2008;3(4):453–67.CrossRef
5.
Zurück zum Zitat Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int. 2013;824563:1–10. Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int. 2013;824563:1–10.
6.
7.
Zurück zum Zitat Meng H, Shen Y, Shen J, Zhou F, Shen S, Das UN. Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro. Lipids Health Dis. 2013;12:160–74.CrossRefPubMedPubMedCentral Meng H, Shen Y, Shen J, Zhou F, Shen S, Das UN. Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro. Lipids Health Dis. 2013;12:160–74.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Bishop KS, Erdrich S, Karunasinghe N, Han DY, Zhu S, Jesuthasan A, et al. An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer. Nutrients. 2015;7:405–22.CrossRefPubMedPubMedCentral Bishop KS, Erdrich S, Karunasinghe N, Han DY, Zhu S, Jesuthasan A, et al. An investigation into the association between DNA damage and dietary fatty acid in men with prostate cancer. Nutrients. 2015;7:405–22.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Park J-M, Kwon S-H, Han Y-M, Hahm K-B, Kim E-H. Omega-3 polyunsaturated fatty acids as potential chemopreventive agent for gastrointestinal cancer. J Cancer Prev. 2013;18(3):1–8. Park J-M, Kwon S-H, Han Y-M, Hahm K-B, Kim E-H. Omega-3 polyunsaturated fatty acids as potential chemopreventive agent for gastrointestinal cancer. J Cancer Prev. 2013;18(3):1–8.
10.
Zurück zum Zitat DiNicolantonio JJ, McCarty MF, Chatterjee S, Lavie CJ, O’Keefe JH (2014) A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas. Nutr & Cancer 0(0): 1–6 DiNicolantonio JJ, McCarty MF, Chatterjee S, Lavie CJ, O’Keefe JH (2014) A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas. Nutr & Cancer 0(0): 1–6
11.
Zurück zum Zitat Fabian CJ and Kimler BF (2013) Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention. ASCO 2013 Educational Book: 97–101. Fabian CJ and Kimler BF (2013) Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention. ASCO 2013 Educational Book: 97–101.
12.
Zurück zum Zitat Kang JX, Liu A. The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013;32:201–10.CrossRefPubMed Kang JX, Liu A. The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013;32:201–10.CrossRefPubMed
13.••
Zurück zum Zitat Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, et al. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer Metastasis Rev. 2015;34:359–80. This review is particularly comprehensive and provides an excellent overview of n-3 FAs in general, as well as their relationship to various cancers and diseases.CrossRefPubMed Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, et al. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer Metastasis Rev. 2015;34:359–80. This review is particularly comprehensive and provides an excellent overview of n-3 FAs in general, as well as their relationship to various cancers and diseases.CrossRefPubMed
14.
Zurück zum Zitat Chung BH, Mitchell SH, Zhang J-S, Young CYF. Effects of DHA and EPA on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis. 2001;22(8):1201–6.CrossRefPubMed Chung BH, Mitchell SH, Zhang J-S, Young CYF. Effects of DHA and EPA on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis. 2001;22(8):1201–6.CrossRefPubMed
15.
Zurück zum Zitat Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, et al. Effect of dietary polyunsaturated FAs on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012;33(2):404–12.CrossRefPubMedPubMedCentral Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, et al. Effect of dietary polyunsaturated FAs on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012;33(2):404–12.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hughes-Fulford M, Chen Y, Tjandrawinata RR. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis. 2001;22(5):701–7.CrossRefPubMed Hughes-Fulford M, Chen Y, Tjandrawinata RR. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis. 2001;22(5):701–7.CrossRefPubMed
17.
Zurück zum Zitat Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br J Cancer. 2006;94:842–53.CrossRefPubMedPubMedCentral Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br J Cancer. 2006;94:842–53.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie H, et al. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 β phosphorylation. Mol Cancer Ther. 2008;7:3203–11.CrossRefPubMed Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie H, et al. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 β phosphorylation. Mol Cancer Ther. 2008;7:3203–11.CrossRefPubMed
19.
Zurück zum Zitat Edwards IJ, O’Flaherty JT. Omega-3 fatty acids and PPARγ in cancer. PPAR Res. 2008;358052:1–14.CrossRef Edwards IJ, O’Flaherty JT. Omega-3 fatty acids and PPARγ in cancer. PPAR Res. 2008;358052:1–14.CrossRef
20.
Zurück zum Zitat Kalish BT, Fallon EM, Puder M. A tutorial on fatty acid biology. J Parenter Enter Nutr. 2012;36:380–90.CrossRef Kalish BT, Fallon EM, Puder M. A tutorial on fatty acid biology. J Parenter Enter Nutr. 2012;36:380–90.CrossRef
21.
Zurück zum Zitat Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217–44.CrossRefPubMed Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217–44.CrossRefPubMed
22.
Zurück zum Zitat Comba A, Lin Y-H, Eynard AR, Valentich MA, Fernandez-Zapico ME, Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev. 2011;30(3–4):325–42.CrossRefPubMedPubMedCentral Comba A, Lin Y-H, Eynard AR, Valentich MA, Fernandez-Zapico ME, Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev. 2011;30(3–4):325–42.CrossRefPubMedPubMedCentral
23.
24.
Zurück zum Zitat Bell GA, Kantor ED, Lampe JW, Kristal AR, Heckbert SR, White E. Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality. Am J Epidemiol. 2014;179(6):710–21.CrossRefPubMedPubMedCentral Bell GA, Kantor ED, Lampe JW, Kristal AR, Heckbert SR, White E. Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality. Am J Epidemiol. 2014;179(6):710–21.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Patel D, Thevenet-Morrison K, van Wijngaarden E (2014) Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: results from the 2003 to 2010 national health and examination survey. Prostaglandins, Leukotrienes Essent Fatty Acids, 1–6 Patel D, Thevenet-Morrison K, van Wijngaarden E (2014) Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: results from the 2003 to 2010 national health and examination survey. Prostaglandins, Leukotrienes Essent Fatty Acids, 1–6
26.
Zurück zum Zitat Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203–27.CrossRefPubMed Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203–27.CrossRefPubMed
27.•
Zurück zum Zitat Liu Z, Hopkins MM, Zhang Z, Quisenberry CB, Fix LC, Galvan BM, et al. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther. 2015;352:1–15. This paper provides evidence of a novel receptor-mediated mechanism of action for n-3 FAs in prostate cancer cells. The doses of n-3 FA used are lower than those used in many other cell culture studies.CrossRef Liu Z, Hopkins MM, Zhang Z, Quisenberry CB, Fix LC, Galvan BM, et al. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther. 2015;352:1–15. This paper provides evidence of a novel receptor-mediated mechanism of action for n-3 FAs in prostate cancer cells. The doses of n-3 FA used are lower than those used in many other cell culture studies.CrossRef
28.
Zurück zum Zitat Al-Zaubai N, Johnstone CN, Leong MM, Li J, Rizzacasa M, Stewart AG. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor. J Pharmacol Exp Ther. 2014;351:172–80.CrossRefPubMed Al-Zaubai N, Johnstone CN, Leong MM, Li J, Rizzacasa M, Stewart AG. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor. J Pharmacol Exp Ther. 2014;351:172–80.CrossRefPubMed
29.
Zurück zum Zitat Gu Z, Wu J, Wang S, Suburu J, Chen H, Thomas MJ, et al. Polyunsaturated fatty acids affect the localization and signaling of PIP3/Akt in prostate cancer cells. Carcinogenesis. 2013;34:1968–75.CrossRefPubMedPubMedCentral Gu Z, Wu J, Wang S, Suburu J, Chen H, Thomas MJ, et al. Polyunsaturated fatty acids affect the localization and signaling of PIP3/Akt in prostate cancer cells. Carcinogenesis. 2013;34:1968–75.CrossRefPubMedPubMedCentral
30.•
Zurück zum Zitat Shin S, Jing K, Jeong S, Kim N, Song K-S, Heo J-Y, Park J-H, Seo K-S, Han J, Park J-I, Kweon G-R, Park S-K, Wu T, Hwang B-D, Lim K (2013) The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. BioMed Research International 2013: 1–11. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer. Shin S, Jing K, Jeong S, Kim N, Song K-S, Heo J-Y, Park J-H, Seo K-S, Han J, Park J-I, Kweon G-R, Park S-K, Wu T, Hwang B-D, Lim K (2013) The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. BioMed Research International 2013: 1–11. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.
31.•
Zurück zum Zitat Li C-C, Hou Y-C, Yeh C-L, Yeh S-L. Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages. PLoS ONE. 2014;9(6):e99630. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMedPubMedCentral Li C-C, Hou Y-C, Yeh C-L, Yeh S-L. Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages. PLoS ONE. 2014;9(6):e99630. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMedPubMedCentral
32.•
Zurück zum Zitat Wang X, Breeze A, Kulka M. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells. Cancer Immunol Immunother. 2015;64:249–58. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMed Wang X, Breeze A, Kulka M. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells. Cancer Immunol Immunother. 2015;64:249–58. This paper provides evidence for a cellular mechanism of action of n-3 FAs in prostate cancer.CrossRefPubMed
33.
Zurück zum Zitat Eser PO, Vanden Heuvel JP, Araujo J, Thompson JT. Marine-and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation. Mol Clin Oncol. 2013;1:444–52.PubMedPubMedCentral Eser PO, Vanden Heuvel JP, Araujo J, Thompson JT. Marine-and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation. Mol Clin Oncol. 2013;1:444–52.PubMedPubMedCentral
34.
Zurück zum Zitat Lupton JR and Chapkin RS (2004) Chemoprotective effects of omega-3 fatty acids. Cancer Chemoprevention: Cancer Drug Discovery and Development, pp 591–608 Lupton JR and Chapkin RS (2004) Chemoprotective effects of omega-3 fatty acids. Cancer Chemoprevention: Cancer Drug Discovery and Development, pp 591–608
35.
Zurück zum Zitat Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:1467S–76S.PubMed Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:1467S–76S.PubMed
36.
Zurück zum Zitat Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013;24:467–74.CrossRefPubMed Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013;24:467–74.CrossRefPubMed
37.
Zurück zum Zitat Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer. 1997;29(2):114–9.CrossRefPubMed Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer. 1997;29(2):114–9.CrossRefPubMed
38.
Zurück zum Zitat Kobayashi N, Barnard J, Henning SM, Elashoff D, Reddy ST, Cohen P, et al. Effect of altering dietary n-6/n-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res. 2006;12(15):4662–70.CrossRefPubMedPubMedCentral Kobayashi N, Barnard J, Henning SM, Elashoff D, Reddy ST, Cohen P, et al. Effect of altering dietary n-6/n-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res. 2006;12(15):4662–70.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Akinsete JA, Ion G, Witte TR, Hardman WE. Consumption of high n-3 FA diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis. 2012;33(1):140–8.CrossRefPubMedPubMedCentral Akinsete JA, Ion G, Witte TR, Hardman WE. Consumption of high n-3 FA diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis. 2012;33(1):140–8.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:64–7.PubMed Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:64–7.PubMed
41.••
Zurück zum Zitat Fu Y-Q, Zheng J-S, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose–response meta-analysis of prospective cohort studies. J Epidemiology. 2015;25(4):261–74. This is a very thorough meta-analysis of the relationship between n-3 FAs and prostate cancer.CrossRef Fu Y-Q, Zheng J-S, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose–response meta-analysis of prospective cohort studies. J Epidemiology. 2015;25(4):261–74. This is a very thorough meta-analysis of the relationship between n-3 FAs and prostate cancer.CrossRef
42.
Zurück zum Zitat Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58(1):47–52.CrossRefPubMed Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58(1):47–52.CrossRefPubMed
43.
Zurück zum Zitat Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1364–70.CrossRefPubMed Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1364–70.CrossRefPubMed
44.
Zurück zum Zitat Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res. 2009;15:2559–66.CrossRefPubMedPubMedCentral Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res. 2009;15:2559–66.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Aronson WJ, Kobayashi N, Barnard RJ, Henning S, Jardack PM, Liu B, et al. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res. 2011;4(12):2062–71.CrossRef Aronson WJ, Kobayashi N, Barnard RJ, Henning S, Jardack PM, Liu B, et al. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res. 2011;4(12):2062–71.CrossRef
46.
Zurück zum Zitat Moreel X, Allaire J, Leger C, Caron A, Labonte M-E, Lamarche B, et al. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res. 2014;7(7):766–76.CrossRef Moreel X, Allaire J, Leger C, Caron A, Labonte M-E, Lamarche B, et al. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res. 2014;7(7):766–76.CrossRef
47.
Zurück zum Zitat Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, et al. Plasma phospholipids FAs and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013;105:1132–41.CrossRefPubMedPubMedCentral Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, et al. Plasma phospholipids FAs and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013;105:1132–41.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Hoffman R and Glew R (2013) Omega-3 fatty acids and prostate cancer: study and stories off-base. Health Care Journalism Hoffman R and Glew R (2013) Omega-3 fatty acids and prostate cancer: study and stories off-base. Health Care Journalism
49.
Zurück zum Zitat Chua ME, Sio MCD, Sorongon MC, Morales Jr ML. The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a meta-analysis. Can Urol Assoc J. 2013;7(5–6):e333–43.PubMedPubMedCentral Chua ME, Sio MCD, Sorongon MC, Morales Jr ML. The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a meta-analysis. Can Urol Assoc J. 2013;7(5–6):e333–43.PubMedPubMedCentral
50.
Zurück zum Zitat Sorongon-Legaspi MK, Chua M, Sio MC, Morales Jr M. Blood level omega-3 fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer. 2013;2013:1–15.CrossRef Sorongon-Legaspi MK, Chua M, Sio MC, Morales Jr M. Blood level omega-3 fatty acids as risk determinant molecular biomarker for prostate cancer. Prostate Cancer. 2013;2013:1–15.CrossRef
51.
Zurück zum Zitat Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E. A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control. 2007;18:1107–21.CrossRefPubMed Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E. A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control. 2007;18:1107–21.CrossRefPubMed
52.
Zurück zum Zitat Shannon J, O’Malley J, Mori M, Garzotto M, Palma AJ, King IB. Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fat Acids. 2010;83:161–9.CrossRef Shannon J, O’Malley J, Mori M, Garzotto M, Palma AJ, King IB. Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fat Acids. 2010;83:161–9.CrossRef
53.
Zurück zum Zitat Brouwer IA, Geleijnse JM, Klaasen VM, Smit LA, Giltay EJ, de Goede J, et al. Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial. PLoS ONE. 2013;8(12), e81519.CrossRefPubMedPubMedCentral Brouwer IA, Geleijnse JM, Klaasen VM, Smit LA, Giltay EJ, de Goede J, et al. Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial. PLoS ONE. 2013;8(12), e81519.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.CrossRefPubMed MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.CrossRefPubMed
55.
Zurück zum Zitat Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita B, et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst. 2014;106(9):dju240.CrossRefPubMedPubMedCentral Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita B, et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst. 2014;106(9):dju240.CrossRefPubMedPubMedCentral
56.••
Zurück zum Zitat Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W. Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer. 2015;67(4):543–54. This is an especially meticulous meta-analysis pf n-3 FAs and human prostate cancer with good parameters and discussion.CrossRefPubMedPubMedCentral Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W. Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer. 2015;67(4):543–54. This is an especially meticulous meta-analysis pf n-3 FAs and human prostate cancer with good parameters and discussion.CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Lovegrove C, Ahmed K, Challavombe B, Khan MS, Popert R, Dasgupta P. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants. Int J Clin Pract. 2015;69(1):87–105.CrossRefPubMed Lovegrove C, Ahmed K, Challavombe B, Khan MS, Popert R, Dasgupta P. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants. Int J Clin Pract. 2015;69(1):87–105.CrossRefPubMed
58.
Zurück zum Zitat Mathias RA, Pani V, Chilton FH. Genetic variants in the FADS gene: implications for dietary recommendations for fatty acid intake. Curr Nutr Rep. 2014;3(2):139–48.CrossRefPubMedPubMedCentral Mathias RA, Pani V, Chilton FH. Genetic variants in the FADS gene: implications for dietary recommendations for fatty acid intake. Curr Nutr Rep. 2014;3(2):139–48.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Hester AG, Murphy RC, Uhlson CJ, Ivester P, Lee TC, Sergeant S, et al. Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem. 2014;289(32):22482–9.CrossRefPubMedPubMedCentral Hester AG, Murphy RC, Uhlson CJ, Ivester P, Lee TC, Sergeant S, et al. Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem. 2014;289(32):22482–9.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Chilton FH, Murphy RC, Wilson BA, Sergeant S, Ainsworth H, Seeds MC, et al. Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients. 2014;6:1993–2022.CrossRefPubMedPubMedCentral Chilton FH, Murphy RC, Wilson BA, Sergeant S, Ainsworth H, Seeds MC, et al. Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients. 2014;6:1993–2022.CrossRefPubMedPubMedCentral
61.
62.
Zurück zum Zitat Zhang P, He X, Tan J, Zhou X, Zou L. β-Arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression. Oncol Rep. 2011;26:1471–7.PubMed Zhang P, He X, Tan J, Zhou X, Zou L. β-Arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression. Oncol Rep. 2011;26:1471–7.PubMed
Metadaten
Titel
Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk
verfasst von
Mandi M. Hopkins
Kathryn E. Meier
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Current Nutrition Reports / Ausgabe 1/2016
Elektronische ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-016-0150-1

Weitere Artikel der Ausgabe 1/2016

Current Nutrition Reports 1/2016 Zur Ausgabe

Dietary Patterns and Behavior (LM Steffen, Section Editor)

The Relationship Between Food Insecurity, Dietary Patterns, and Obesity

Dietary Patterns and Behavior (LM Steffen, Section Editor)

Dietary Patterns in the Frail Elderly

Cancer (MF Leitzmann, Section Editor)

Adolescent Diet and Breast Cancer Risk

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.